Nothing Special   »   [go: up one dir, main page]

DE60112949D1 - Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes - Google Patents

Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes

Info

Publication number
DE60112949D1
DE60112949D1 DE60112949T DE60112949T DE60112949D1 DE 60112949 D1 DE60112949 D1 DE 60112949D1 DE 60112949 T DE60112949 T DE 60112949T DE 60112949 T DE60112949 T DE 60112949T DE 60112949 D1 DE60112949 D1 DE 60112949D1
Authority
DE
Germany
Prior art keywords
patient
complex
lipoprotein
formation
acutphase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60112949T
Other languages
English (en)
Other versions
DE60112949T2 (de
Inventor
J Fischer
Colin Downey
Mike Nesheim
A Samis
Liliana Tejidor
Hock Toh
B Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux Inc
Original Assignee
Biomerieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Inc filed Critical Biomerieux Inc
Application granted granted Critical
Publication of DE60112949D1 publication Critical patent/DE60112949D1/de
Publication of DE60112949T2 publication Critical patent/DE60112949T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/557—Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60112949T 2000-06-09 2001-06-08 Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes Expired - Lifetime DE60112949T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59164200A 2000-06-09 2000-06-09
US591642 2000-06-09
PCT/US2001/018611 WO2001096864A2 (en) 2000-06-09 2001-06-08 A method for detecting a lipoprotein-acute phase protein complex

Publications (2)

Publication Number Publication Date
DE60112949D1 true DE60112949D1 (de) 2005-09-29
DE60112949T2 DE60112949T2 (de) 2006-05-18

Family

ID=26680497

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60112949T Expired - Lifetime DE60112949T2 (de) 2000-06-09 2001-06-08 Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes

Country Status (10)

Country Link
US (1) US20070155018A1 (de)
EP (1) EP1309857B1 (de)
JP (1) JP5051960B2 (de)
AT (1) ATE302947T1 (de)
AU (2) AU2001266795B2 (de)
BR (1) BR0111987A (de)
CA (1) CA2412317C (de)
DE (1) DE60112949T2 (de)
MX (1) MXPA02012176A (de)
WO (1) WO2001096864A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282368B2 (en) 2002-02-27 2007-10-16 Biomerieux, Inc. Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
EP1575978A4 (de) 2002-11-12 2006-04-19 Becton Dickinson Co Sepsis- oder sirs-diagnose mittels biomarkerprofilen
US20040157242A1 (en) 2002-11-12 2004-08-12 Becton, Dickinson And Company Diagnosis of sepsis or SIRS using biomarker profiles
US20060147998A1 (en) * 2004-12-01 2006-07-06 Jones Gregory R Method for diagnosing and monitoring critically ill patients
EP1869463A4 (de) 2005-04-15 2010-05-05 Becton Dickinson Co Sepsisdiagnose
JP5125608B2 (ja) * 2008-02-28 2013-01-23 東ソー株式会社 イオン交換クロマトグラフィーによる血液中のＬｐ（ａ）の分離方法
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
GB201223079D0 (en) 2012-12-20 2013-02-06 Sepsis Ltd Point of care sepsis assay device and method
GB201301611D0 (en) * 2013-01-30 2013-03-13 Shaw Andrew M Systems and methods for medical data processing and analysis
GB202004047D0 (en) * 2020-03-20 2020-05-06 Ainger Phill Point of care sepsis assay device and method
CN113252852B (zh) * 2021-06-04 2021-10-22 金科环境股份有限公司 絮凝剂性能评价与检验设备及方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample

Also Published As

Publication number Publication date
DE60112949T2 (de) 2006-05-18
BR0111987A (pt) 2003-10-28
US20070155018A1 (en) 2007-07-05
AU6679501A (en) 2001-12-24
JP5051960B2 (ja) 2012-10-17
CA2412317C (en) 2016-03-22
WO2001096864A3 (en) 2003-02-06
EP1309857A2 (de) 2003-05-14
WO2001096864A2 (en) 2001-12-20
EP1309857B1 (de) 2005-08-24
JP2004503254A (ja) 2004-02-05
MXPA02012176A (es) 2004-08-19
AU2001266795B2 (en) 2006-07-13
ATE302947T1 (de) 2005-09-15
CA2412317A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
ATE489633T1 (de) Verfahren zum frühzeitigen nachweis herzerkrankungen
DE50111644D1 (de) Verfahren und vorrichtung zum nachweisen von substanzen in körperflüssigkeiten mittels raman-spektroskopie
WO2004113912A8 (en) System and method for determining a temperature during analysis of biological fluid
ATE509275T1 (de) Schnelltest für glykiertes albumin
ATE361470T1 (de) Verfahren zur diagnose von immunologischer lebensmittelsensitivität
ATE497361T1 (de) Verfahren zum nachweis von mehreren analyten
DE59504495D1 (de) Verfahren und vorrichtung zur analyse von glucose in einer biologischen probe
DE602004030586D1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
DK1077634T3 (da) Monitorering af fysiologiske analytter
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
DE60112949D1 (de) Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes
ATE316653T1 (de) Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe
US5197017A (en) Potentiophotometric fibrinogen determination
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
ATE403012T1 (de) Schnelle quantitative messung von löslichem fibrin in opaken körperflüssigkeiten
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
ATE314648T1 (de) Diagnostisches verfahren für asthma
WO1996016588A3 (en) Method and apparatus for diagnosing capillary leak
ATE377191T1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
DE69929817D1 (de) Verfahren zur aktivitätsbestimmung einer substanz mittels eines funktionellen in vitro tests
NO20016080D0 (no) Analyse
ATE466285T1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
ATE445840T1 (de) Immuntest für humanes medullasin und verfahren zur diagnose von multipler sklerose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition